GB00BP2C3V08
© ACCESSWIRE
11.12.2025
GENF
LISTED
LSE
Genflow to Attend Healthcare Conference
News Preview
Genflow to Attend the 44th Annual J.P. Morgan Healthcare Conference LONDON, UK / ACCESS Newswire / December 11, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), a leading European-based biotechnology company focusing on longevity, announces that it will attend the 44th Annual J.P. Morgan Healt...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
31.10.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Total Voting Rights
News Preview
LONDON, UK / ACCESS Newswire / October 31, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases, announces that the total issued share capital of the Compan...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.10.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Holding(s) in Company
News Preview
LONDON, UK / ACCESS Newswire / October 24, 2025 / TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJonathan Mark SwannCity of...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ACCESSWIRE
22.10.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Second European Patent Application
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ACCESSWIRE
20.10.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Recognition of Patentability of Claims
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.10.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Update on Animal Health Program
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.10.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
02.10.2025
GENF
LISTED
LSE
Correction - Genflow Biosciences PLC Announces Issue of Equity
News Preview
The following amendment has been made to the 'Subscription of New Ordinary Shares, Warrant Issue, PDMR Dealings' announcement released on 01 October 2025.The sentence "being the bid price as at close of business on 1 October 2025" has been corrected to "being a 35% discount to the bid price as at close of business on 1 October 2025.&...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
02.10.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Issue of Equity
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Half-Year Report
News Preview
LONDON, UNITED KINGDOM / ACCESS Newswire / September 30, 2025 / Genflow (LSE:GENF)(OTCQB:GENFF) is pleased to announce its half year results for the six-month period ended 30 June 2025.Chairman's StatementIt is my pleasure to update shareholders of Genflow Biosciences Plc ("Genflow" or the "Company") on our performance during th...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.09.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Holding(s) in Company
News Preview
LONDON, UK / ACCESS Newswire / September 19, 2025 / TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJonathan Mark SwannCity...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.09.2025
GENF
LISTED
LSE
Genflow Strengthens IP Portfolio
News Preview
Genflow Strengthens Global IP Portfolio with China Patent Examination Filing for SIRT6 Variants in NASH LONDON, UK / ACCESS Newswire / September 19, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, today announces that it has filed a formal...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ACCESSWIRE
15.09.2025
GENF
LISTED
LSE
Genflow Signs CDAs with Animal Health Companies
News Preview
Genflow Signs CDAs with Animal Health Companies to Advance Longevity Gene Therapy Platform LONDON, UK / ACCESS Newswire / September 15, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, today announces that it has signed two Confidential Dis...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
18.08.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Company Update on Dog Trials
News Preview
Genflow Advances World's First Longevity Gene Therapy Trial in Dogs with No Adverse Effects Reported LONDON, UK / ACCESS Newswire / August 18, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, provides an update on its Dog Aging (GF-1004) st...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.07.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Clinical Readiness Acceleration
News Preview
Clinical Readiness Accelerates Across Genflow Biosciences Lead Programs LONDON, UK / ACCESS Newswire / July 24, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is pleased to report key preclinical activities in two of its lead programs.GF-...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
17.07.2025
GENF
LISTED
LSE
Genflow Confirms Progression of Grant
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
17.06.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Corporate Update
News Preview
Genflow Biosciences Provides Half Year Corporate Update on SIRT6 Programs, IP Progress and Strategic Partnerships LONDON, UK / ACCESS Newswire / June 17, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is pleased to provide an update on th...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.05.2025
GENF
LISTED
LSE
Genflow Biosciences and CER Sign Master Service Agreement to Strengthen Long-Term R&D Collaboration
News Preview
LONDON, UK / ACCESS Newswire / May 28, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is pleased to announce the signing of a Master Service Agreement (MSA) with CER Groupe (CER), a long-standing partner of the Company.CER is a private Be...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.05.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces AGM Notice
News Preview
LONDON, UNITED KINGDOM / ACCESS Newswire / May 22, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that it will hold its Annual G...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.05.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Key SIRT6 Patent Application
News Preview
LONDON, UNITED KINGDOM / ACCESS Newswire / May 15, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, announces that the Japanese Patent Office has advanced its SIRT6-related patent application (Application No. JP 2024515284) to the national...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
12.05.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Holding(s) in Company
News Preview
Please note that from 22 March 2021, the Standard TR-1 Form should be completed and submitted to the FCA via our Electronic Submission System (ESS) in relation to notifications of voting rights held in issuers whose shares are admitted to trading on UK regulated markets.Holders of voting rights in issuers whose shares are admitted to trading on UK...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.05.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Share Subscription, Director's Dealing and Update
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Genf...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.04.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Final Results
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.04.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Launch of AI-Powered Partnership
News Preview
Genflow Biosciences Signs MSA with Heureka Labs, Launching AI-Powered Partnership in Gene Therapy Research LONDON, UNITED KINGDOM / ACCESS Newswire / April 14, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is pleased to announce that, in...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.04.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Launches New Development Program
News Preview
Genflow Biosciences Launches New Ophthalmology Development ProgramSigns MTA with Leading Ophthalmology Company LONDON, UK / ACCESS Newswire / April 10, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is excited to announce the launch of a...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.03.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Holding in Company
News Preview
LONDON, UNITED KINGDOM / ACCESS Newswire / March 28, 2025 / 1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameMR ERIC LEIRECity of registered office (if applicable)15 Ingestre Plac...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.03.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Director Dealings
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.03.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Institutional Investment
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
20.02.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application
News Preview
LONDON, UK / ACCESS Newswire / February 20, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce today that its exclusive, out-license...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.01.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Holding(s) in Company - 2
News Preview
TR-1: Standard form for notification of major holdings LONDON, UNITED KINGDOM / ACCESSWIRE / January 13, 2025 / 1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJonathan Mark Swa...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.01.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Holding(s) in Company - 1
News Preview
TR-1: Standard form for notification of major holdings LONDON, UNITED KINGDOM / ACCESSWIRE / January 13, 2025 / 1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of financial instruments3. Details of person subject to the notification obligationNamePremier Mi...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.01.2025
GENF
LISTED
LSE
Genflow Biosciences PLC Announces 2024 Highlights
News Preview
Genflow Biosciences Plc("Genflow" or "the Company")A Look Back at an Exciting 2024 LONDON, UNITED KINGDOM / ACCESSWIRE / January 6, 2025 / 2024 has been an incredible year for Genflow as we advance our mission to develop novel therapeutics that promote a longer, healthier life.Our focus on the SIRT6 gene and its potential to slo...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.10.2024
GENF
LISTED
LSE
Genflow Secures Non-Dilutive Financial Support
News Preview
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SE...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2024
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Half-year Report
News Preview
LONDON, UNITED KINGDOM / ACCESSWIRE / September 30, 2024 / Genflow (LSE:GENF) is pleased to announce its half year results for the six-month period ended 30 June 2024.Chairman's StatementIt is with pleasure that I take this opportunity to update shareholders of Genflow Biosciences Plc ("Genflow" or the "Company") on the Company'...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
